-
Alzheimer’s: First drug to slow progression of disease gains approval of US regulator the FDA | Science & Tech News
admin
The US Food and Drug Administration (FDA) has fully approved a drug that slows the progression of Alzheimer’s disease for the first time. The FDA has granted full regulatory approval to Leqembi – a drug by Japanese manufacturers Eisai and US drugmakers Biogen. Up to now, other approved drugs targeted only the symptoms of the…
-
approval, brain, chip, company, Elon, FDA, human, Musks, Neuralink, News, Science, Tech, trials, won
Elon Musk’s brain chip company Neuralink says it has won FDA approval for human trials | Science & Tech News
admin
Elon Musk’s brain chip firm Neuralink has said it has been given the go-ahead to start carrying out studies on humans. Neuralink said in a tweet on Thursday it had won the approval of the US Food and Drug Administration (FDA) “to launch our first-in-human clinical study!” It represents “an important first step that will…